BIZENGRI
- Product NDC
- 83077-100
- 11-digit product format
- 830770100
- Labeler code
- 83077
- Product ID
- 83077-100_0ba12e0b-78b7-4ef0-b8fd-5127f0b16581
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zenocutuzumab
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Merus US, Inc.
- Application
- BLA761352
- Marketing category
- BLA
- Marketing start
- 2024-12-04
- Substance
- ZENOCUTUZUMAB
- Active strength
- 20 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| AE72RB1W1X | ZENOCUTUZUMAB | 1969309-56-5 | ZENOCUTUZUMAB |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 83077-100-02 | 83077010002 | 2 VIAL, GLASS in 1 CARTON (83077-100-02) / 18.75 mL in 1 VIAL, GLASS (83077-100-01) | 2024-12-04 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| BIZENGRI | Merus US, Inc. | 2025-01-17 | HUMAN PRESCRIPTION DRUG LABEL | 2 |